In the BioHarmony Drug Report Database
Chlorprothixene
Taractan (chlorprothixene) is a small molecule pharmaceutical. Chlorprothixene was first approved as Taractan on 1982-01-01. It is used to treat paranoid schizophrenia and psychotic disorders in the USA.
Trade Name
|
Taractan |
|---|---|
Common Name
|
chlorprothixene |
ChEMBL ID
|
CHEMBL908 |
Indication
|
paranoid schizophrenia, psychotic disorders |
Drug Class
|
Typical antipsychotic |
Image (chem structure or protein)